Miriam Merad

Miriam Merad

Icahn School of Medicine at Mount Sinai

H-index: 125

North America-United States

About Miriam Merad

Miriam Merad, With an exceptional h-index of 125 and a recent h-index of 98 (since 2020), a distinguished researcher at Icahn School of Medicine at Mount Sinai, specializes in the field of Immunology.

His recent articles reflect a diverse array of research interests and contributions to the field:

A phase II open-label randomized clinical trial of preoperative durvalumab or durvalumab plus tremelimumab in resectable head and neck squamous cell carcinoma

Persistent complement dysregulation with signs of thromboinflammation in active Long Covid

An IL-4 signalling axis in bone marrow drives pro-tumorigenic myelopoiesis

Embracing cancer complexity: Hallmarks of systemic disease

Single cell view of tumor microenvironment gradients in pleural mesothelioma

Abstract B075: Spatial genomics identifies cancer cell cytokines regulating ovarian cancer immunity

An immunogenetic basis for lung cancer risk

16. Circulating Myeloid-Derived MMP8 in Stress Susceptibility and Depression

Miriam Merad Information

University

Position

___

Citations(all)

85229

Citations(since 2020)

52508

Cited By

50117

hIndex(all)

125

hIndex(since 2020)

98

i10Index(all)

272

i10Index(since 2020)

248

Email

University Profile Page

Icahn School of Medicine at Mount Sinai

Google Scholar

View Google Scholar Profile

Miriam Merad Skills & Research Interests

Immunology

Top articles of Miriam Merad

Title

Journal

Author(s)

Publication Date

A phase II open-label randomized clinical trial of preoperative durvalumab or durvalumab plus tremelimumab in resectable head and neck squamous cell carcinoma

Clinical Cancer Research

Chang Gon Kim

Min Hee Hong

Dahee Kim

Brian Hyohyoung Lee

Hyunwook Kim

...

2024/4/3

Persistent complement dysregulation with signs of thromboinflammation in active Long Covid

Science

Carlo Cervia-Hasler

Sarah C Brüningk

Tobias Hoch

Bowen Fan

Giulia Muzio

...

2024/1/19

An IL-4 signalling axis in bone marrow drives pro-tumorigenic myelopoiesis

Nature

Nelson M LaMarche

Samarth Hegde

Matthew D Park

Barbara B Maier

Leanna Troncoso

...

2024/1/4

Embracing cancer complexity: Hallmarks of systemic disease

Charles Swanton

Elsa Bernard

Chris Abbosh

Fabrice André

Johan Auwerx

...

2024/3/28

Single cell view of tumor microenvironment gradients in pleural mesothelioma

bioRxiv

Bruno Giotti

Komal Dolasia

william Zhao

Peiwen Cai

Robert Sweeney

...

2024

Abstract B075: Spatial genomics identifies cancer cell cytokines regulating ovarian cancer immunity

Cancer Research

Gurkan Mollaoglu

Alexander Tepper

Hunter Potak

Luisanna Pia

Angelo Amabile

...

2024/3/4

An immunogenetic basis for lung cancer risk

Science

Chirag Krishna

Anniina Tervi

Miriam Saffern

Eric A Wilson

Seong-Keun Yoo

...

2024/2/23

16. Circulating Myeloid-Derived MMP8 in Stress Susceptibility and Depression

Biological Psychiatry

Flurin Cathomas

Hsiao-Yun Lin

Kenny Chan

Long Li

Lyonna Parise

...

2024/5/15

Circulating myeloid-derived MMP8 in stress susceptibility and depression

Nature

Flurin Cathomas

Hsiao-Yun Lin

Kenny L Chan

Long Li

Lyonna F Parise

...

2024/2/7

Circulating senescent myeloid cells infiltrate the brain and cause neurodegeneration in histiocytic disorders

Immunity

C Matthias Wilk

Flurin Cathomas

Orsolya Török

Jessica Le Berichel

Matthew D Park

...

2023/12/12

TREM2 macrophages drive NK cell paucity and dysfunction in lung cancer

Nature immunology

Matthew D Park

Ivan Reyes-Torres

Jessica LeBerichel

Pauline Hamon

Nelson M LaMarche

...

2023/5

650 Neoadjuvant ezabenlimab or pembrolizumab in combination with an anti-SIRPα antibody in resectable colorectal cancer

Natalie Lucas

Nicholas Venturini

Samarth Hegde

Raphaël Mattiuz

Clotilde Hennequin

...

2023/11/1

Circulating tumor DNA (ctDNA) correlates closely with tumor necrosis and relapse-free survival (RFS) in hepatocellular carcinoma (HCC) patients treated with perioperative …

Cancer Research

Thomas U Marron

Laura Brennan

Pauline Hamon

Maria Isabel Fiel

Stephen C Ward

...

2023/4/4

AXL limits the mobilization of cholesterol to regulate dendritic cell maturation and the immunogenic response to cancer

bioRxiv

Matthew Dae-Young Park

Meriem Belabed

Miriam Merad

2023

Molecular states during acute COVID-19 reveal distinct etiologies of long-term sequelae

Nature Medicine

Ryan C Thompson

Nicole W Simons

Lillian Wilkins

Esther Cheng

Diane Marie Del Valle

...

2023/1

LBA4 Low-dose stereotactic body radiotherapy prior to pre-operative cemiplimab for patients with resectable hepatocellular carcinoma

Immuno-Oncology and Technology

TU Marron

O Hapanowicz

N Lucas

K Wu

M Buckstein

...

2023/12/1

Circulating proteins to predict COVID-19 severity

Scientific Reports

Chen-Yang Su

Sirui Zhou

Edgar Gonzalez-Kozlova

Guillaume Butler-Laporte

Elsa Brunet-Ratnasingham

...

2023/4/17

MacroH2A restricts inflammatory gene expression in melanoma cancer-associated fibroblasts by coordinating chromatin looping

Nature Cell Biology

Dan Filipescu

Saul Carcamo

Aman Agarwal

Navpreet Tung

Étienne Humblin

...

2023/9

Proteomic Characterization of Acute Kidney Injury in Patients Hospitalized with SARS-CoV2 Infection

Communications Medicine

Ishan Paranjpe

Pushkala Jayaraman

Chen-Yang Su

Sirui Zhou

Steven Chen

...

2023/6/12

Circulating senescent myeloid cells drive blood brain barrier breakdown and neurodegeneration

bioRxiv

Christian Matthias Wilk

Flurin Cathomas

Orsolya Torok

Jessica Le Berichel

Matthew D Park

...

2023

See List of Professors in Miriam Merad University(Icahn School of Medicine at Mount Sinai)